Research
-
Contribution Of Care Source To Cancer Treatment Cost Variation In The US Military Health System
Seth Seabury and colleagues examined how care received from military treatment facilities or purchased care in civilian facilities contributed to cancer treatment costs for patients.
-
Influence of Out-of-Network Payment Standards on Insurer–Provider Bargaining: California’s Experience
California’s experience implementing a policy to address surprise medical billing demonstrates that out-of-network payment standards can influence payer–provider bargaining leverage, affecting prices and network breadth.
Categorized in -
Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer’s Treatment
A report on Canadian readiness to deal with new Alzheimer’s disease treatments co-authored by Jakub Hlávka found that average wait times could reach 28 months and that the most pressing issue is a lack of dementia specialists.
-
Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey
This paper examines racial/ethnic disparity in prescription drug cost-coping behaviors in a nationally representative sample of Medicare beneficiaries.
Categorized in -
Regression to the Mean in the Medicare Hospital Readmissions Reduction Program
Regression to the mean is a known statistical phenomenon. It occurs when an outcome is measured multiple times. Outcomes that are extreme relative to the statistical average, or mean, during the first measurement are more likely to be closer to the mean in subsequent measurement periods simply by chance, because more extreme values have a […]
Categorized in -
Do Cancer Treatments Have Option Value? Real‐ World Evidence From Metastatic Melanoma
The study findings in metastatic melanoma provide the first empirical evidence of the impact of option value in cancer treatment decision making.
Categorized in -
Value-Based Contracting in Healthcare: What Is It and How Can It Be Achieved?
Value-based contracts must incentivize the clinical decision maker, usually the physician, to allocate treatment based on both price and value. Changing certain elements in the financing system could create an environment for successful value-based contracting without having to reform the entire system.
Categorized in -
Three Ways to Make Health Insurance Auto-Enrollment Work
Successful auto-enrollment likely requires changes to the way we determine eligibility for Medicaid and Marketplace financial assistance, to make the system easier to navigate and more generous, writes USC-Brookings Schaeffer Initiative Fellow Christen Linke Young.
-
Factors Associated with Unintended Pregnancy, Contraceptive Risk-Taking, and Interest in Pharmacist-Provided Birth Control
Although overall rates of unplanned pregnancies have declined, significant racial and geographic disparities persist. At the same time, there are new opportunities to improve access to contraception. This study identifies contributors to the high rate of unplanned pregnancies in a rural farming community in California and assesses interest in pharmacist-prescribed contraception.
Categorized in -
Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling
Peer-reviewed journals could make a key contribution to improving scientific rigor and real-world healthcare decision-maker acceptability by requiring that VHDM models, source code, and data used in published articles be made freely available to interested readers.
Categorized in